Black Rose IndusQ1 FY25

Black Rose Indus Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹106.74P/E: 15.7Market Cap: ₹544 CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

N/A

Order

N/A

Capex

Yes

1 of 3 growth signals are positive — mixed outlook.

Full analysis

Revenue guidance

Category 3
  • The company expects substantial growth in sales during the current quarter, particularly for the Polyacrylamide solid product as R&D progresses and the plant setup is imminent.
  • Strong support and good allocation from principals are driving higher demand in the domestic chemical distribution business, leading to increased sales volume and profitability.
  • Export volumes from the US oil and gas sector remain steady, with efforts to expand the product portfolio and customer base aimed at boosting sales further.
  • An increase in market share is anticipated in both local and export markets, particularly for Acrylamide liquid and solid products.
  • The introduction of newer, more robust binder versions and ongoing trials of Polyacrylate based dispersants are expected to enhance acceptance and volumes in the Polyacrylamide liquid segment.
  • The company is actively pursuing new projects, acquisitions of land for future expansion, and setting up new manufacturing units as opportunities arise.

See what Black Rose Indus management said on margin guidance — free account, 30 seconds.

Fundraise plans

  • There is no mention of any current or planned fundraising through debt or equity in the transcript.
  • The company is currently 100% long-term debt-free and has sufficient reserves to meet future requirements.
  • Identified CapEx projects include a specialty chemicals plant with an expected CapEx of ₹20-30 crores.
  • Additional CapEx relates to an ongoing EC application project and land acquisition for future projects.
  • No specific plans for raising funds via debt or equity have been disclosed; expansions and CapEx are planned to be funded through existing resources.

See what Black Rose Indus management said on order book — free account, 30 seconds.

Capex plans

Yes
  • Specialty chemical plant CapEx expected between ₹20-30 crores; product details undisclosed due to secrecy agreements.
  • Another project with Environment Clearance (EC) application filed and under process, involving additional CapEx.
  • Land acquisition underway for future projects; a 20-acre land bank identified for upcoming expansions.
  • Ongoing R&D focused on Polyacrylamide solid product development, with plant setup planned post R&D completion by fiscal year-end.
  • Company actively strengthening team and R&D capabilities to support current and new product innovation.
  • Always exploring new manufacturing opportunities in collaboration with principals, with potential future CapEx allocations accordingly.

Track Black Rose Indus — get its next earnings analysis in your feed

How does Black Rose Indus rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisBlack Rose Indus
Rev 3Mar 3

How does Black Rose Indus rank in Chemicals & Petrochemicals?

Compare Black Rose Indus against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →